Radiopharmaceuticals/Nuclear Medicine Market Size, Share, Growth Report To 2030

The report "Radiopharmaceuticals/Nuclear Medicine Market by Product Type (Diagnostic Radiopharmaceuticals (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals) and Therapeutic Radiopharmaceuticals (Beta Emitters, Alpha emitters, Brachytherapy, and Others)), by Application (Oncology, Neurological disorders, Cardiovascular diseases, Thyroid, and Others), by Route of Administration (Oral, Inhalation, and Parenteral) by End User (Hospitals, Clinics, Diagnostic Centers, and Research Institutes), - Global Forecasts to 2030" The global Radiopharmaceuticals/Nuclear Medicine Market is projected to reach USD 5605 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17441 Competitive Dashboard: The prominent key players operating in the global Radiopharmaceuticals/Nuclear Medicine Market are Advanced Accelerator Applications Ba...